CUPERTINO, Calif.–(BUSINESS WIRE)–Apple® today announced John Giannandrea, Apple’s senior vice president for Machine Learning and AI Strategy, is stepping down from his position and will serve as an advisor to the company before…
IT: Welcome to Derry had a solid showing in its first full week of streaming, bringing in the best single week result for an HBO or HBO Max original series in five months.
The prequel to the IT films drew 620 million…
We knew Tommy Egan’s origin story would be among those told in Power: Origins. Well, everyone originates with a mom, for better and for worse — especially in this case.
On Monday, Starz revealed it has cast Jennifer Ferrin in the role…
Crystal Lake, Illinois, December 1, 2025 – AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has acquired Sommaplast, a specialized provider of oral dosing pharma packaging solutions, such as closures, droppers, dispensers and dosing cups, based in Brazil.
“Aptar has manufactured in Brazil for 25 years and this acquisition is expected to further reinforce our footprint in the region. It also helps position us to capitalize on Brazil’s fast-growing oral dosing, over-the-counter and nutraceutical markets. This growth is driven by an expanding population, rising middle class and aging demographic,” explained Gael Touya, President, Aptar Pharma.
Sommaplast was founded over 20 years ago and operates from a facility in Sao Paulo, Brazil with a team of over 400 employees. Today, Sommaplast is recognized for its strong team, deep customer relationships and high level of dosing know-how. With this acquisition, Aptar is building on its over 80-year history innovation and excellence. Aptar currently has manufacturing facilities in Cajamar, Jundiaí, Maringá and Camaçari, Brazil and this transaction expands the company’s presence in Latin America and brings together shared manufacturing strengths.
Further building on the acquisition rationale, Touya said, “We plan to further extend Sommaplast’s offerings in the oral dosing pharma markets through its strong commercial capabilities and expanded product offering. Together, our operational synergies and precision injection molding expertise will greatly benefit customers. We intend to maintain the DNA of Sommaplast’s family-owned company, while leveraging our global network of solutions, services and product experts.”
Read the full press release here.
About Aptar
Aptar is a global leader in drug and consumer product dosing, dispensing and protection technologies. Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using market expertise, proprietary design, engineering and science to create innovative solutions for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com.
Astronomers have discovered 53 new supermassive black hole-powered quasars that are blasting out jets of matter at near light-speed that stretch out for up to 7.2 million light-years, around 50 times the width of the Milky Way.
These monster…
Judith Moritz,Special correspondentand
Daniel Wittenberg,Senior Producer
ReutersFamilies of some of those killed in the Hillsborough disaster fear…
An Ebola outbreak in the Democratic Republic of Congo is now over, Congolese health officials and the U.N.’s World Health Organization said on Monday, after the country went 42 consecutive days without recording a new case.
The outbreak, declared…